PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas - Concepedia

Concepedia

Publication | Open Access

PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas

DOI Full Paper Access

50

Citations

24

References

2013

Year

Katherine Walsh, Matthew McKinney, Cassandra Love, Qingquan Liu, Alice C. Fan, Amee B. Patel, Jason P. Smith, Anne Beaven, Dereje D. Jima, Sandeep S. Davé

Clinical Cancer Research

Abstract

Thus, we show that PI3K inhibition is broadly effective in lymphomas and PAK1 is a key modulator of resistance to PI3K inhibition.

References

	Year	Citations
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Aravind Subramanian, Pablo Tamayo, Vamsi K. Mootha, Proceedings of the National Academy of Sciences GeneticsGenomicsGene RecognitionBioinformatics DatabaseGene Expression Profiling	2005	54.5K
Cluster analysis and display of genome-wide expression patterns Michael B. Eisen, Paul T. Spellman, Patrick O. Brown, Proceedings of the National Academy of Sciences Functional GenomicsEngineeringGene RecognitionGeneticsComputational Genomics	1998	16.3K
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Ash A. Alizadeh, Michael B. Eisen, R. Eric Davis, Nature Hematological MalignancyLymphoid NeoplasiaImmunologyDistinct TypesPathology	2000	9.9K
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Ting‐Chao Chou, Paul Talalay Advances in Enzyme Regulation Pharmacological StudyPharmacoepidemiologyQuantitative AnalysisPharmacologyDose-effect Relationships	1984	7.1K
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Lindsay M. Morton, Sophia Wang, Susan S. Devesa, Blood	2005	1.7K
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells Sandeep S. Davé, George W. Wright, Bruce K. Tan, New England Journal of Medicine	2004	1.4K
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling Michael Hummel, Stefan Bentink, Hilmar Berger, New England Journal of Medicine	2006	1K
Molecular Diagnosis of Burkitt's Lymphoma Sandeep S. Davé, Kai Fu, George W. Wright, New England Journal of Medicine	2006	902
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response Stefano Monti Blood	2004	817
NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations Violeta Serra, Ben Markman, Maurizio Scaltriti, Cancer Research	2008	795

Page 1